Scientific Brain Training SA

MLSBT.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MLSBT.PA stands at N/A. In comparison, CLARI.PA has a market cap of 1.35B. Regarding current trading prices, MLSBT.PA is priced at $5.30, while CLARI.PA trades at $3.78.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MLSBT.PA currently has a P/E ratio of -17.10, whereas CLARI.PA's P/E ratio is -29.08. In terms of profitability, MLSBT.PA's ROE is -0.10%, compared to CLARI.PA's ROE of -0.00%. Regarding short-term risk, MLSBT.PA is less volatile compared to CLARI.PA. This indicates potentially lower risk in terms of short-term price fluctuations for MLSBT.PA.

MLSBT.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MLSBT.PA stands at N/A. In comparison, ORP.PA has a market cap of 1.34B. Regarding current trading prices, MLSBT.PA is priced at $5.30, while ORP.PA trades at $8.39.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MLSBT.PA currently has a P/E ratio of -17.10, whereas ORP.PA's P/E ratio is 0.06. In terms of profitability, MLSBT.PA's ROE is -0.10%, compared to ORP.PA's ROE of +0.77%. Regarding short-term risk, MLSBT.PA is less volatile compared to ORP.PA. This indicates potentially lower risk in terms of short-term price fluctuations for MLSBT.PA.

MLSBT.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MLSBT.PA stands at N/A. In comparison, GDS.PA has a market cap of 1.07B. Regarding current trading prices, MLSBT.PA is priced at $5.30, while GDS.PA trades at $9.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MLSBT.PA currently has a P/E ratio of -17.10, whereas GDS.PA's P/E ratio is -13.47. In terms of profitability, MLSBT.PA's ROE is -0.10%, compared to GDS.PA's ROE of -0.07%. Regarding short-term risk, MLSBT.PA is less volatile compared to GDS.PA. This indicates potentially lower risk in terms of short-term price fluctuations for MLSBT.PA.

MLSBT.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MLSBT.PA stands at N/A. In comparison, KORI.PA has a market cap of 778.56M. Regarding current trading prices, MLSBT.PA is priced at $5.30, while KORI.PA trades at $7.36.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MLSBT.PA currently has a P/E ratio of -17.10, whereas KORI.PA's P/E ratio is 29.44. In terms of profitability, MLSBT.PA's ROE is -0.10%, compared to KORI.PA's ROE of +0.01%. Regarding short-term risk, MLSBT.PA is less volatile compared to KORI.PA. This indicates potentially lower risk in terms of short-term price fluctuations for MLSBT.PA.

MLSBT.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MLSBT.PA stands at N/A. In comparison, LNA.PA has a market cap of 241.31M. Regarding current trading prices, MLSBT.PA is priced at $5.30, while LNA.PA trades at $23.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MLSBT.PA currently has a P/E ratio of -17.10, whereas LNA.PA's P/E ratio is 11.08. In terms of profitability, MLSBT.PA's ROE is -0.10%, compared to LNA.PA's ROE of +0.07%. Regarding short-term risk, MLSBT.PA is less volatile compared to LNA.PA. This indicates potentially lower risk in terms of short-term price fluctuations for MLSBT.PA.

MLSBT.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MLSBT.PA stands at N/A. In comparison, PNSB.BR has a market cap of 245000.00. Regarding current trading prices, MLSBT.PA is priced at $5.30, while PNSB.BR trades at $0.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MLSBT.PA currently has a P/E ratio of -17.10, whereas PNSB.BR's P/E ratio is N/A. In terms of profitability, MLSBT.PA's ROE is -0.10%, compared to PNSB.BR's ROE of N/A. Regarding short-term risk, MLSBT.PA and PNSB.BR have similar daily volatility (0.00).

MLSBT.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MLSBT.PA stands at N/A. In comparison, ESP.AS comparison data is unavailable. Regarding current trading prices, MLSBT.PA is priced at $5.30, while ESP.AS trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MLSBT.PA currently has a P/E ratio of -17.10, whereas ESP.AS's P/E ratio is -0.01. In terms of profitability, MLSBT.PA's ROE is -0.10%, compared to ESP.AS's ROE of +2.64%. Regarding short-term risk, MLSBT.PA is less volatile compared to ESP.AS. This indicates potentially lower risk in terms of short-term price fluctuations for MLSBT.PA.